The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Research in genetics and biotechnology has advanced by leaps and bounds in recent years, offering new hope for the treatment ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.

ORNL’s invention may change plastic’s environmental fate by rearranging ... Similarly, in 2020, the prize went to developers ...

A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...

In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), ...

Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.